1. Home
  2. FGEN vs PRTS Comparison

FGEN vs PRTS Comparison

Compare FGEN & PRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • PRTS
  • Stock Information
  • Founded
  • FGEN 1993
  • PRTS 1995
  • Country
  • FGEN United States
  • PRTS United States
  • Employees
  • FGEN N/A
  • PRTS N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • PRTS Auto & Home Supply Stores
  • Sector
  • FGEN Health Care
  • PRTS Consumer Discretionary
  • Exchange
  • FGEN Nasdaq
  • PRTS Nasdaq
  • Market Cap
  • FGEN 45.1M
  • PRTS 40.0M
  • IPO Year
  • FGEN 2014
  • PRTS 2007
  • Fundamental
  • Price
  • FGEN $8.66
  • PRTS $0.48
  • Analyst Decision
  • FGEN Strong Buy
  • PRTS Hold
  • Analyst Count
  • FGEN 2
  • PRTS 1
  • Target Price
  • FGEN $146.50
  • PRTS $0.70
  • AVG Volume (30 Days)
  • FGEN 31.2K
  • PRTS 888.6K
  • Earning Date
  • FGEN 11-10-2025
  • PRTS 11-10-2025
  • Dividend Yield
  • FGEN N/A
  • PRTS N/A
  • EPS Growth
  • FGEN N/A
  • PRTS N/A
  • EPS
  • FGEN 53.38
  • PRTS N/A
  • Revenue
  • FGEN $8,298,000.00
  • PRTS $560,632,000.00
  • Revenue This Year
  • FGEN N/A
  • PRTS N/A
  • Revenue Next Year
  • FGEN N/A
  • PRTS $2.62
  • P/E Ratio
  • FGEN $0.16
  • PRTS N/A
  • Revenue Growth
  • FGEN N/A
  • PRTS N/A
  • 52 Week Low
  • FGEN $4.85
  • PRTS $0.46
  • 52 Week High
  • FGEN $21.94
  • PRTS $1.42
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 25.08
  • PRTS 30.58
  • Support Level
  • FGEN $8.30
  • PRTS $0.46
  • Resistance Level
  • FGEN $11.39
  • PRTS $0.65
  • Average True Range (ATR)
  • FGEN 0.51
  • PRTS 0.04
  • MACD
  • FGEN -0.26
  • PRTS -0.01
  • Stochastic Oscillator
  • FGEN 12.95
  • PRTS 8.79

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About PRTS CarParts.com Inc.

CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.

Share on Social Networks: